Jason Thompson: Seeing the Big Picture in Clinical Research
Senior Project Manager, Confidence Pharmaceutical Research Jason Thompson didn’t plan a career in clinical research. In fact, when he graduated from college, he didn’t know it was a career option. He was working in a laboratory when his contract ended and found himself searching for his next role. Then a CRO found his CV and […]
A Career Built on Curiosity: A Conversation with Inna Nemirovskaya
For Inna Nemirovskaya, clinical research was never just a career choice. It became a lifelong journey that began more than two decades ago and continues to shape the way she thinks about science, people, and the impact of data. Before entering clinical research, Inna trained and worked as a physician, caring for pediatric patients with […]
Pavel Tikhonov: Creating Alignment in Clinical Research
For Pavel Tikhonov, good project management comes down to one main focus: alignment. A clinical trial brings together sponsors, investigators, sites, vendors and cross-functional teams, all with different priorities, pressures and areas of expertise. Pavel sees an important part of his role as making sure those different groups understand one another and remain focused […]
In Memory of Petr Denisov
Remembering a deeply respected colleague whose life and work were inseparable from clinical research. It is with profound sadness that we share the passing of our colleague and friend, Petr Denisov. Petr was a physician and scientist whose career spanned emergency medicine, clinical research, scientific due diligence and biomedical venture capital. At Confidence, he served […]
Global Protocol Amendments: Keeping Every Region Moving Forward Despite Different Regulatory Timelines
A protocol amendment may be approved globally on one date, but it rarely becomes operational globally on one date. In a multinational clinical trial, the same amendment can move through very different regulatory pathways and timelines. A change may be ready for implementation relatively quickly in one country while another is still progressing through regulatory […]